We conducted a pilot study followed by a large clinical trial in Nepal of the use of the capsular polysaccharide of Salmonella typhi (Vi) as a vaccine to prevent typhoid fever. In the pilot study, involving 274 Nepalese, there were no significant side effects of the Vi vaccine; about 75 percent responded with a rise in serum antibodies of fourfold or more. In the clinical trial, residents of five villages were given intramuscular injections of either Vi or, as a control, pneumococcus vaccine dispensed in coded, randomly arranged, single-dose syringes. There were 6907 participants, of whom 6438 were members of the target population (5 to 44 years of age); each was visited every two days. Those with temperatures of 37.8 degrees C or higher for three consecutive days were examined and asked to give blood for culture. Typhoid was diagnosed as either blood culture-positive or clinically suspected on the basis of bradycardia, splenomegaly, and fever, with a negative blood culture. Seventeen months after vaccination, the codes were broken for the 71 patients meeting the criteria for either culture-positive or clinically suspected typhoid. The attack rate of typhoid was 16.2 per 1000 among the controls and 4.1 per 1000 among those immunized with Vi (P less than 0.00001). The efficacy of Vi was 72 percent in the culture-positive cases, 80 percent in the clinically suspected cases, and 75 percent in the two groups combined. These data provide evidence that Vi antibodies confer protection against typhoid. Surveillance continues to determine the duration of Vi-induced immunity.
Source Information
Infectious Disease Hospital and Central Health Laboratory, Teku, Nepal.
This article has been cited by other articles:
Pulickal, A. S., Gautam, S., Clutterbuck, E. A., Thorson, S., Basynat, B., Adhikari, N., Makepeace, K., Rijpkema, S., Borrow, R., Farrar, J. J., Pollard, A. J.
(2009). Kinetics of the Natural, Humoral Immune Response to Salmonella enterica Serovar Typhi in Kathmandu, Nepal. CVI
16: 1413-1419
[Abstract][Full Text]
Sur, D., Ochiai, R. L., Bhattacharya, S. K., Ganguly, N. K., Ali, M., Manna, B., Dutta, S., Donner, A., Kanungo, S., Park, J. K., Puri, M. K., Kim, D. R., Dutta, D., Bhaduri, B., Acosta, C. J., Clemens, J. D.
(2009). A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India. NEJM
361: 335-344
[Abstract][Full Text]
Levine, M. M.
(2009). Typhoid Vaccines Ready for Implementation. NEJM
361: 403-405
[Full Text]
Basu, S., Lurie, P., Bhattarai, A., Innis, B. L., Shrestha, M. P., Scott, R. M.
(2007). Hepatitis E Vaccine. NEJM
356: 2421-2422
[Full Text]
Wain, J., House, D., Zafar, A., Baker, S., Nair, S., Kidgell, C., Bhutta, Z., Dougan, G., Hasan, R.
(2005). Vi Antigen Expression in Salmonella enterica Serovar Typhi Clinical Isolates from Pakistan. J. Clin. Microbiol.
43: 1158-1165
[Abstract][Full Text]
Sharma, A., Qadri, A.
(2004). Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. USA
101: 17492-17497
[Abstract][Full Text]
Canh, D. G., Lin, F.-y., Thiem, V. D., Trach, D. D., Trong, N. D., Mao, N. D., Hunt, S., Schneerson, R., Robbins, J. B., Chu, C., Shiloach, J., Bryla, D. A., Bonnet, M.-C., Schulz, D., Szu, S. C.
(2004). Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children. Infect. Immun.
72: 6586-6588
[Abstract][Full Text]
Moore, S. E, Jalil, F., Ashraf, R., Chen Szu, S., Prentice, A. M, Hanson, L. A
(2004). Birth weight predicts response to vaccination in adults born in an urban slum in Lahore, Pakistan. Am. J. Clin. Nutr.
80: 453-459
[Abstract][Full Text]
Chibber, S., Bhardwaj, S. B.
(2004). Protection in a mouse peritonitis model mediated by iron-regulated outer-membrane protein of Salmonella typhi coupled to its Vi antigen. J Med Microbiol
53: 705-709
[Abstract][Full Text]
Appenheimer, M. M., Huang, R.-Y., Chandrasekaran, E.V., Dalziel, M., Hu, Y. P., Soloway, P. D., Wuensch, S. A., Matta, K. L., Lau, J. T.Y.
(2003). Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology
13: 591-600
[Abstract][Full Text]
Mastroeni,, P., Menager, N.
(2003). Development of acquired immunity to Salmonella. J Med Microbiol
52: 453-459
[Abstract][Full Text]
Parry, C. M., Hien, T. T., Dougan, G., White, N. J., Farrar, J. J.
(2002). Typhoid Fever. NEJM
347: 1770-1782
[Full Text]
McDade, T. W, Beck, M. A, Kuzawa, C., Adair, L. S
(2001). Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am. J. Clin. Nutr.
74: 543-548
[Abstract][Full Text]
Wang, J. Y., Pasetti, M. F., Noriega, F. R., Anderson, R. J., Wasserman, S. S., Galen, J. E., Sztein, M. B., Levine, M. M.
(2001). Construction, Genotypic and Phenotypic Characterization, and Immunogenicity of Attenuated {Delta}guaBA Salmonella enterica Serovar Typhi Strain CVD 915. Infect. Immun.
69: 4734-4741
[Abstract][Full Text]
Lin, F. Y. C., Ho, V. A., Khiem, H. B., Trach, D. D., Bay, P. V., Thanh, T. C., Kossaczka, Z., Bryla, D. A., Shiloach, J., Robbins, J. B., Schneerson, R., Szu, S. C., Lanh, M. N., Hunt, S., Trinh, L., Kaufman, J. B.
(2001). The Efficacy of a Salmonella typhi Vi Conjugate Vaccine in Two-to-Five-Year-Old Children. NEJM
344: 1263-1269
[Abstract][Full Text]
Wang, J. Y., Noriega, F. R., Galen, J. E., Barry, E., Levine, M. M.
(2000). Constitutive Expression of the Vi Polysaccharide Capsular Antigen in Attenuated Salmonella enterica Serovar Typhi Oral Vaccine Strain CVD 909. Infect. Immun.
68: 4647-4652
[Abstract][Full Text]
McSorley, S. J., Jenkins, M. K.
(2000). Antibody Is Required for Protection against Virulent but Not Attenuated Salmonella enterica Serovar Typhimurium. Infect. Immun.
68: 3344-3348
[Abstract][Full Text]
Winslow, G. M., Yager, E., Shilo, K., Volk, E., Reilly, A., Chu, F. K.
(2000). Antibody-Mediated Elimination of the Obligate Intracellular Bacterial Pathogen Ehrlichia chaffeensis during Active Infection. Infect. Immun.
68: 2187-2195
[Abstract][Full Text]
Tacket, C. O., Sztein, M. B., Wasserman, S. S., Losonsky, G., Kotloff, K. L., Wyant, T. L., Nataro, J. P., Edelman, R., Perry, J., Bedford, P., Brown, D., Chatfield, S., Dougan, G., Levine, M. M.
(2000). Phase 2 Clinical Trial of Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers. Infect. Immun.
68: 1196-1201
[Abstract][Full Text]
Kossaczka, Z., Lin, F.-Y. C., Ho, V. A., Thuy, N. T. T., Bay, P. V., Thanh, T. C., Khiem, H. B., Trach, D. D., Karpas, A., Hunt, S., Bryla, D. A., Schneerson, R., Robbins, J. B., Szu, S. C.
(1999). Safety and Immunogenicity of Vi Conjugate Vaccines for Typhoid Fever in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam. Infect. Immun.
67: 5806-5810
[Abstract][Full Text]
Engels, E. A, Falagas, M. E, Lau, J., Bennish, M. L
(1998). Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. BMJ
316: 110-116
[Abstract][Full Text]
Zenilman, J. M.
(1997). Typhoid Fever. JAMA
278: 847-850
[Abstract]
Jones, B D
(1997). Host responses to pathogenic Salmonella infection.. Genes Dev.
11: 679-687
Clemens, J., Brenner, R., Rao, M., Tafari, N., Lowe, C.
(1996). Evaluating New Vaccines for Developing Countries: Efficacy or Effectiveness?. JAMA
275: 390-397
[Abstract]
Plotkin, S. A., Cam, N. B.-L.
(1995). A New Typhoid Vaccine Composed of the Vi Capsular Polysaccharide. Arch Intern Med
155: 2293-2299
[Abstract]
Mathieu, J. J., Henning, K. J., Bell, E., Frieden, T. R.
(1994). Typhoid Fever in New York City, 1980 Through 1990. Arch Intern Med
154: 1713-1718
[Abstract]
Woodruff, B. A., Pavia, A. T., Blake, P. A.
(1991). A New Look at Typhoid Vaccination: Information for the Practicing Physician. JAMA
265: 756-759
[Abstract]
Schwartz, E., Shlim, D. R., Eaton, M., Jenks, N., Houston, R.
(1990). The Effect of Oral and Parenteral Typhoid Vaccination on the Rate of Infection With Salmonella typhi and Salmonella paratyphi A Among Foreigners in Nepal. Arch Intern Med
150: 349-351
[Abstract]
HILL, D. R., PEARSON, R. D.
(1988). Health Advice for International Travel. ANN INTERN MED
108: 839-852
[Abstract]
(1987). A BETTER TYPHOID VACCINE. JWatch General
1987: 4-4
[Full Text]
